ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Boostrix, Injektionssuspension - 10
00637004 GlaxoSmithKline AG
Boostrix, Injektionssuspension10.08.2000
  10.08.2000
Pertussis, Purified Antigen, Combinations with Toxoids (J07AJ52) 
WHO-DDD 
08.08.10
08.08. 
B  
No 
IP 
PR  
k.A.PR
  
7680006370043Impfstoffe
  
Composition
toxoidum diphtheriae ≥ 2 U.I., toxoidum tetani ≥ 20 U.I., toxoidum pertussis 8 µg, haemagglutininum filamentosum 8 µg, pertactinum 2.5 µg, aluminium ut aluminii phosphas et aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.8 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, polysorbatum 80, formaldehydum.
Packungsbestandteile
Active Agent
Vaccinum Diphtheriae Adsorbatum
Vaccinum Pertussis Acell. Adsorbatum
Vaccinum Tetani Adsorbatum
BAG: Active AgentDose
Toxoidum Diphtheriae2 UI
Toxoidum Pertussis8 mcg
Toxoidum Tetani20 UI
Source
Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home